Biotech3 hours ago
Beeline Medicines Launches with $300M to Advance Precision Therapies for Autoimmune Diseases
Beeline Medicines launches globally with $300M funding and Bristol Myers Squibb assets to develop precision therapies for autoimmune and inflammatory diseases. Led by Saqib Islam, it...